Medclick Pharma

Imalek contains Imatinib Mesylate, a targeted cancer therapy classified as a tyrosine kinase inhibitor (TKI). Imatinib works by blocking the action of certain proteins called tyrosine kinases, which are involved in the growth and proliferation of cancer cells. By inhibiting these enzymes, Imatinib slows down or stops the spread of cancer.

Veenat contains imatinib, a targeted cancer therapy medication classified as a tyrosine kinase inhibitor. It works by blocking specific proteins that promote the growth of cancer cells, helping to slow or stop their spread.

Imatero 400mg contains Imatinib Mesylate, a targeted therapy used in the treatment of certain cancers such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting specific tyrosine kinases involved in cancer cell growth and division.

Imatib 400mg contains Imatinib Mesylate, a tyrosine kinase inhibitor used to treat cancers such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by blocking abnormal proteins that promote the growth of cancer cells, helping to slow or stop disease progression.